PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q2 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,218,178 | +125.9% | 209,856 | +201.7% | 0.57% | +29.9% |
Q2 2020 | $982,000 | -24.9% | 69,564 | -51.1% | 0.44% | -42.4% |
Q1 2020 | $1,308,000 | +946.4% | 142,223 | +678.9% | 0.76% | +1154.1% |
Q3 2019 | $125,000 | -86.4% | 18,259 | -75.9% | 0.06% | -84.4% |
Q2 2019 | $917,000 | – | 75,791 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |